http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201591300-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201591300-A1
titleOfInvention FORMS OF MEGLUMIN SALT 2 - ((1R, 4R) -4- (4- (5- (BENZOXAZOL-2-ILAMINO) Pyridine-2-IL) PHENIL) CYCLOHEXIL) ACETIC ACID AND THEIR APPLICATION AS QUEST
abstract The invention relates to new crystalline forms of the meglumine salt 2 - ((1R, 4R) -4- (4- (5- (benzo [d] oxazol-2-ylamino) pyridin-2-yl) phenyl) cyclohexyl) acetic acid of the formula ( I) and their use in the treatment or prevention of a condition or disorder associated with DGAT1 activity in animals, especially humans.
priorityDate 2013-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44887
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464460
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84497
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID482093
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282609
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8617825
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID816464
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515558

Total number of triples: 44.